| NASDAQ (usa) |
 |
6715.56 | -12.11 | -0.18% |
| FTSE 100 (london) |
|
7487.96 | -5.12 | -0.07% |
| DAX (german) |
 |
13465.51 | 235.94 | 1.78% |
| NIKKEI 225 (japan) |
|
22420.08 | 408.47 | 1.86% |
| Hang - Seng (hong kong) |
|
28594.06 | 348.52 | 1.23% |
| NIFTY - 50 (india) | ||||
| Straits Times (singapore) |
|
3391.61 | 17.53 | 0.52% |
| KOSPI (korea) |
|
2556.47 | 33.04 | 1.31% |
| All Ordinaries (australia) |
|
6005.30 | 28.90 | 0.48% |
| BOVESPA (brazil) |
|
74092.76 | -215.73 | -0.29% |
Calliditas Therapeutics AB (publ) (NASDAQ: CALT)
CALT Technical Analysis
4
| As on 9th Jun 2023 CALT STOCK Price closed @ 17.10 and we RECOMMEND Sell for LONG-TERM with Stoploss of 18.11 & Strong Sell for SHORT-TERM with Stoploss of 21.73 we also expect STOCK to react on Following IMPORTANT LEVELS. |
CALTSTOCK Price
| Open | 16.94 | Change | Price | % |
| High | 17.47 | 1 Day | -0.09 | -0.52 |
| Low | 16.57 | 1 Week | -0.74 | -4.15 |
| Close | 17.10 | 1 Month | -8.26 | -32.57 |
| Volume | 12400 | 1 Year | -6.38 | -27.17 |
| 52 Week High 26.32 | 52 Week Low 11.50 | ||||
NASDAQ USA Most Active Stocks
| TSLA | 244.40 | 4.06% |
| TTOO | 0.07 | -12.50% |
| SOFI | 8.18 | 0.74% |
| FFIE | 0.33 | 6.45% |
| PONO | 1.72 | 2.38% |
| AMD | 124.92 | 3.20% |
| IDEX | 0.06 | 0.00% |
| NKLA | 0.70 | 14.75% |
| AMZN | 123.43 | -0.66% |
| AAPL | 180.96 | 0.22% |
NASDAQ USA Top Gainers Stocks
NASDAQ USA Top Losers Stocks
| CALT Daily Charts |
CALT Intraday Charts |
Whats New @ Bazaartrend |
CALT Free Analysis |
|
|
CALT Important Levels Intraday
| RESISTANCE | 18.83 |
| RESISTANCE | 18.28 |
| RESISTANCE | 17.93 |
| RESISTANCE | 17.59 |
| SUPPORT | 16.61 |
| SUPPORT | 16.27 |
| SUPPORT | 15.92 |
| SUPPORT | 15.37 |
CALT Forecast May 2024
| 4th UP Forecast | 29.39 |
| 3rd UP Forecast | 25.45 |
| 2nd UP Forecast | 23.01 |
| 1st UP Forecast | 20.58 |
| 1st DOWN Forecast | 13.62 |
| 2nd DOWN Forecast | 11.19 |
| 3rd DOWN Forecast | 8.75 |
| 4th DOWN Forecast | 4.81 |
CALT Weekly Forecast
| 4th UP Forecast | 21.03 |
| 3rd UP Forecast | 19.77 |
| 2nd UP Forecast | 18.99 |
| 1st UP Forecast | 18.21 |
| 1st DOWN Forecast | 15.99 |
| 2nd DOWN Forecast | 15.21 |
| 3rd DOWN Forecast | 14.43 |
| 4th DOWN Forecast | 13.17 |
CALT Forecast2024
| 4th UP Forecast | 47.59 |
| 3rd UP Forecast | 37.81 |
| 2nd UP Forecast | 31.77 |
| 1st UP Forecast | 25.72 |
| 1st DOWN Forecast | 8.48 |
| 2nd DOWN Forecast | 2.43 |
| 3rd DOWN Forecast | -3.61 |
| 4th DOWN Forecast | -13.39 |
Calliditas Therapeutics AB (publ) ( NASDAQ USA Symbol : CALT )
Sector : Healthcare And Other Stocks in Same Sector
Sector : Healthcare And Other Stocks in Same Sector
CALT Business Profile
Calliditas Therapeutics AB (publ), a clinical-stage biopharmaceutical company, focused on identifying, developing, and commercializing pharmaceuticals products for treatments in orphan indications with initial focus on renal and hepatic diseases. The company's lead product candidate is Nefecon, a oral formulation of budesonide that is an immunosuppressant for the treatment of the autoimmune renal disease IgA nephropathy. Calliditas Therapeutics AB (publ) was founded in 2004 and is headquartered in Stockholm, Sweden. Address: Kungsbron 1, C8, Stockholm, Sweden, 111 22
© 2005-2023 BazaarTrend.com All rights reserved.
Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service
Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service